Concentra Group Holdings Parent Inc

Análisis de la acción Concentra Group Holdings Parent Inc (CON)

$39.250

-0.707 (-1.80%)Al cierre

Loading chart…
Máximo
39.950
Apertura
39.770
Precio medio ponderado por volumen
39.48
Volumen
1.28M
Capitalización
—
Mínimo
39.240
Importe
50.53M
EV/EBITDA, TTM
12.42

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. The Company delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care. It supports the care of approximately 54,000 patients each business day on average across 46 states and the District of Columbia at its 633 occupational health centers, 415 onsite health clinics at employer worksites, and Concentra Telemed. Its segments include Occupational health centers, Onsite health clinics, and Other businesses. Occupational health centers segment encompasses the services that it delivers at its occupational health center facilities across the United States. Onsite health clinics segment delivers occupational health services and/or employer-sponsored primary care services. The Other businesses segment comprises several complementary services, such as Concentra Pharmacy, and Concentra Medical Compliance Administration.

ir.concentra.com

Análisis de IA of Concentra Group Holdings Parent Inc (CON)

Comprar

Concentra Group Holdings is a good buy right now due to its current price of $38.54 being below the average analyst price target of $40, indicating potential upside. Additionally, the company's gross margin has improved significantly to 28.41%, and the forward P/E ratio is a reasonable 18.018, suggesting that the stock is fairly valued relative to its growth prospects. The main risk is the high debt to equity ratio of 310.73%, which could impact financial flexibility.

Métricas de valoración

El PER previsto actual de Concentra Group Holdings Parent Inc (CON) es 18.02, frente a su media de 5 años de 16.52.

PER previsto

Valor razonable
Media 5A P/E
16.52
P/E actual
18.02
Sobrevalorada
18.91
Infravalorada
14.14

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
11.69
EV/EBITDA actual
12.42
Sobrevalorada
13.25
Infravalorada
10.13

Precio/ventas previsto

Muy sobrevalorado
Media 5A P/S
1.34
P/S actual
2.00
Sobrevalorada
1.55
Infravalorada
1.13

Ballenas con CON en cartera

C

Cramer Rosenthal McGlynn LLC

+ Con en carteraCON

-11.19%

Rentabilidad a 3 meses

Cronología de eventos

2026-09-14 (ET)

09:30:00

Concentra Opens New Medical Center in Florida

2026-09-08 (ET)

09:30:00

Concentra Appoints Tanner Newton as CFO

2026-07-20 (ET)

11:00:00

Concentra Opens First Medical Center in Idaho

2026-07-13 (ET)

09:31:00

Concentra Opens New Medical Center in Missouri

Noticias

Preguntas frecuentes sobre CON, respondidas por Alphio AI

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. The Company delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care. It supports the care of approximately 54,000 patients each business day on average across 46 states and the District of Columbia at its 633 occupational health centers, 415 onsite health clinics at employer worksites, and Concentra Telemed. Its segments include Occupational health centers, Onsite health clinics, and Other businesses. Occupational health centers segment encompasses the services that it delivers at its occupational health center facilities across the United States. Onsite health clinics segment delivers occupational health services and/or employer-sponsored primary care services. The Other businesses segment comprises several complementary services, such as Concentra Pharmacy, and Concentra Medical Compliance Administration. It operates in the Healthcare sector.

Concentra Group Holdings is a good buy right now due to its current price of $38.54 being below the average analyst price target of $40, indicating potential upside. Additionally, the company's gross margin has improved significantly to 28.41%, and the forward P/E ratio is a reasonable 18.018, suggesting that the stock is fairly valued relative to its growth prospects. The main risk is the high debt to equity ratio of 310.73%, which could impact financial flexibility.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar